Zeotap Gmbh, a consumer behaviour-focussed customer intelligence platform, has extended its Series C fundraise with an additional infusion of $18.5 million (Rs 137.67 crore at current exchange rates).
The Berlin- and Bengaluru-based company has raised this capital from SignalFire, a San Francisco-based venture firm that focusses on investments across the seed and early growth stages.
Zeotap secured this capital exactly four months after it said it raised $42 million in its Series C round from investors including Neue Capital, Coparion, Kathaka – the family office of Caroline Rupert – and MathCapital.
This takes the total capital raised by Zeotap in this round to $60.5 million. In a statement, the company said the funding extension has come in the wake of increased demand for its customer data intelligence capabilities.
Zeotap was founded in 2014 by Projjol Banerjea, Daniel Heer and Stephan Schwebe. Its platform provides clients with integrated modules such as customer data unification, identity resolution, enrichment, analytics, and modelling.
It will use the Series C capital to invest in its customer data platform and ID+, its universal marketing identity solution. It will also accelerate the adoption of its platform across its 14 active markets.
“COVID-19 has catalysed a transformation in the marketing mix as brands invest in their data and learnings to redirect traditional TV budgets to more effective channels. Our investment in Zeotap is testament to our belief in the company’s leadership,” SignalFire venture partner Chris Scoggins said.
Zeotap says it has worked with brands including Mercedes-Benz, BBVA, Orange Telecom, Vodafone, and Red Bull.
In January 2017, Zeotap raised $12.8 million in its Series B funding round from New Science Ventures and HERE. Capnamic Ventures and Iris Capital also participated in that round.
It had raised $6.4 million in Series A funding from Capnamic Ventures, Iris Capital and other investors in April 2015 and secured seed funding from HitFox Group and other angel investors.
Comments